SGO Issues August 7, 2014
SGO publishes 2015 Staging Handbook
SGO endometrial cancer white papers published
SGO Practice Survey now available for full/candidate GYN/ONCs
SGO members work to secure $20M for DOD ovarian cancer research
Robert Coleman urges giving to Foundation for Gynecologic Oncology
Past ACS leader Thomas Russell dies
SGO has published the fourth edition of its Staging of Gynecologic Malignancies Handbook. It includes the revised 2014 International Federation of Gynecology and Obstetrics (FIGO) ovarian cancer staging, new FIGO sarcoma staging, and 2009 FIGO staging for cervical, endometrial and vulvar sites. Order here.
In his foreword to the fourth edition, David Mutch, MD, of Washington University in St. Louis, said the handbook is meant to serve as a quick reference for physicians, nurses and other health care professionals involved in the care and treatment of gynecologic malignancies.
“Like other cancer sites, staging for gynecologic malignancies has continued to evolve and as such, there are areas of the staging algorithms that remain controversial,” he added. “These controversies are carefully addressed under each subsection.”
Authors of the fourth edition are Jonathan A. Cosin, MD, FACOG, FACS, The Hospital of Central Connecticut; Joshua P. Kesterson, MD, Penn State College of Medicine; and Alexander B. Olawaiye, MD, University of Pittsburgh.
The handbook is available in PDF and print format. Be sure to log in to receive the member price.
“The two papers are important for SGO members because they represent a collaborative effort by our Society to provide all health care professionals involved in caring for women with endometrial cancer with a document highlighting coordinated, comprehensive, and quality care,” said lead author William M. Burke, MD.
“We also believe these papers provide our members with a fantastic reference to help educate our colleagues in other specialties, gynecologic oncology fellows, obstetrics and gynecology residents, medical students, and other individuals interested in learning how to care for women with endometrial cancer,” he said.
Dr. Burke added that the take home message from both papers should be that health care providers taking care of women with endometrial cancer have an evidence-based framework from which to build their treatment plan. Decisions on the work-up, treatment, and surveillance of patients with endometrial cancer should be built upon this framework to ensure high quality patient care.
Other endometrial working group members include James Orr, MD, FACOG, FACS; Mario M. Leitao, Jr., MD, FACOG; Emery M. Salom, MD; Paola A. Gehrig, MD; Alexander B. Olawaiye, MD; Molly A. Brewer, MD; David M. Boruta, II, MD; Jeannine Villella, DO; Thomas Herzog, MD; and Fadi Abu Shahinm, MD.
DEADLINE EXTENDED: SGO’s Practice Survey is now open until Oct. 13, giving members an opportunity to submit their data regarding important practice parameters. The previous edition was published in 2010. A link to the survey was most recently sent on Thursday, Sept. 4, by SGO to members qualified to participate. If you did not receive a link to the survey, please contact Jessica Oldham and your individual link will be sent to you.
Members who complete the survey will receive the full report at no charge.
Full and candidate Gynecologic Oncologist members in the United States and Canada are encouraged to complete this survey, which thoroughly addresses demographics, practice characteristics, practice activities, income and other valuable information. Results will be published in the 2015 edition of “Gynecologic Oncology: State of the Subspecialty.” The previous edition was published in 2010. The 2015 report will inform physicians, hospital administrators, industry, insurers and woman’s cancer care teams about the current, present and future state of gynecologic oncology.
Updated survey questions are organized into a number of important categories, including Practice Characteristics, Practice Activities, Professional Liability, Demographics, Benefits, Physician Expenses, Income and Revenue.
“The results of this survey will be crucial to SGO members as you prepare to address the emerging and changing health care landscape, and will serve as a strategic guide for the future of your practice,” said Howard Muntz, MD, Co-Chair of the SGO Practice Survey Taskforce.
“The survey results will also have an important impact on a variety of audiences including hospital administration, industry partners, your employees, members of the subspecialty and your care teams.”
The final report will be available prior to the SGO Annual Meeting in Chicago, March 28 – 31, 2015.
Members of the SGO Government Relations Committee are preparing this fall to contact Members of Congress on the Appropriations Committees and those who have signed letters in support of budgeting $20 million for the ovarian cancer research program at the Department of Defense (DoD).
As has been the case for the last several years, this summer the U.S. House of Representatives approved $20 million for the DoD ovarian cancer research program for FY 2015. The Senate Appropriations Committee approved $10 million for the program.
The House and the Senate are expected to pass a continuing resolution by Sept. 30, 2014, to keep the government operating and then address the FY 2015 appropriations process after the November elections, probably with a large “omnibus” appropriations bill that funds most government agencies.
The SGO Government Relations Committee once again will contact Members of Congress to ask them to appropriate $20 million as the final FY 2015 budgeted amount for the DoD’s ovarian cancer research program in the omnibus bill. SGO members who would like to assist the committee with their efforts can contact Jill Rathbun at Jill_Rathbun@galileogrp.com.
Gifts to the Foundation for Gynecologic Oncology provide essential resources that help further the subspecialty of gynecologic oncology. Learn more about reasons to donate from Robert L. Coleman, MD, Foundation Development Committee Chair and SGO President Elect I, and consider making an online donation today.
Thomas R. Russell, MD, FACS, former Executive Director of the American College of Surgeons (ACS) and a physician who helped champion the subspecialty of gynecologic oncology, passed away on Aug. 4. Dr. Russell served as the ACS Executive Director from January 2000 to January 2010. Read more about Dr. Russell’s legacy on the ACS website.